Oncology and Hematology - Global Oncology Academy

81-96 of 651

Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CE
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Charles E. Geyer Jr., MD, FACP; Komal Jhaveri, MD, FACP
0.25 credits
- Charles E. Geyer Jr., MD, FACP
- Komal Jhaveri, MD, FACP
0.25 credits
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Jennifer Caudle, DO, FACOFP; Mansi R. Shah, MD
- Jennifer Caudle, DO, FACOFP
- Mansi R. Shah, MD
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Ryan Quigley
- Ryan Quigley
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Project Oncology®
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Pavani Chalasani, MD, MPH; Virginia Borges, MD
- Pavani Chalasani, MD, MPH
- Virginia Borges, MD
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Predicting Breast Cancer Metastasis with Proteomics
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®
Predicting Breast Cancer Metastasis with Proteomics
Does BMI Matter in mBC Outcomes?
Does BMI Matter in mBC Outcomes?
Project Oncology®
Does BMI Matter in mBC Outcomes?
Advancing HER2-Targeted Therapy in GI Cancers
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®
Advancing HER2-Targeted Therapy in GI Cancers
John H. Strickler, MD
- John H. Strickler, MD
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast Cancer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP; Heather Parsons
- Charles Turck, PharmD, BCPS, BCCCP
- Heather Parsons
How AI Is Transforming Biomarker Development in GI Oncology
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®
How AI Is Transforming Biomarker Development in GI Oncology
William Hall, MD
- William Hall, MD
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Project Oncology®
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Daniela Molena, MD
- Daniela Molena, MD
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
Project Oncology®
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
Pavani Chalasani, MD, MPH; Alison Stopeck, MD
- Pavani Chalasani, MD, MPH
- Alison Stopeck, MD
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast Cancer
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Ashley Baker, MSN, PMHNP; Nick McAndrew, MD, MSCE
- Ashley Baker, MSN, PMHNP
- Nick McAndrew, MD, MSCE
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
On the Frontlines of Metastatic Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Jules Cohen, MD
- Jules Cohen, MD

Previous
1
2
…
4
5
6
7
8
…
40
41
Next

6/11